APA (7th ed.) Citation

A, B., RL, E., M, X., CS, E., F, H., KA, M., . . . DF, H. (2024). Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo. The Journal of infectious diseases, 229(5), 1498. https://doi.org/10.1093/infdis/jiad441

Chicago Style (17th ed.) Citation

A, Blazevic, et al. "Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo." The Journal of Infectious Diseases 229, no. 5 (2024): 1498. https://doi.org/10.1093/infdis/jiad441.

MLA (9th ed.) Citation

A, Blazevic, et al. "Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo." The Journal of Infectious Diseases, vol. 229, no. 5, 2024, p. 1498, https://doi.org/10.1093/infdis/jiad441.